Showing 17,021 - 17,040 results of 129,113 for search '(( i e decrease ) OR ( 5 ((point decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 2.31s Refine Results
  1. 17021
  2. 17022
  3. 17023
  4. 17024
  5. 17025
  6. 17026
  7. 17027
  8. 17028

    Decreased retrograde flow via lowered blood viscosity affects valve morphogenesis. by Julien Vermot (257990)

    Published 2009
    “…(E–H) Confocal sections of the valve-forming region in (E) control, (F) <i>gata1</i>, (G) <i>gata2</i>, and (H) <i>gata1/2</i> morphants. …”
  9. 17029

    Validation of MAFB to be a direct target of miR-199a-5p in NT2 cells. by Shen Gu (503795)

    Published 2013
    “…<p>A) Western blot showing expression decreased at protein level of MAFB after miR-199a-5p transfection; B) Luciferase receptor assay demonstrated direct binding between MAFB and miR-199a-5p. 3′-UTR of MAFB containing miR-199a-5p targeting site (MAFB) was cloned to the 3′-end of firefly luciferase (pGL vector). …”
  10. 17030

    Inhibition of <i>miR-10b</i> in HTR8 cells affects expression of targets <i>E-cadherin</i> and <i>KLF4</i>. by Shanthie Thamotharan (3992894)

    Published 2017
    “…<p>(4A) <i>miR-10b</i> expression levels in HTR8 cells at baseline control conditions, and after transfection with inhibitor. (4B) <i>E-cadherin</i> gene expression by qRT-PCR decreases after inhibition of <i>miR-10b</i> in HTR8 cells, compared to control conditions. (4C) <i>KLF4</i> gene expression by qRT-PCR increases after inhibition of <i>miR-10b</i> in HTR8 cells. …”
  11. 17031
  12. 17032
  13. 17033
  14. 17034
  15. 17035
  16. 17036
  17. 17037
  18. 17038
  19. 17039

    What works best for whom? Cognitive Behavior Therapy and Mindfulness-Based Cognitive Therapy for depressive symptoms in patients with diabetes by K. Annika Tovote (4183234)

    Published 2017
    “…</p><p>Methods</p><p>The sample consisted of 91 adult outpatients with type 1 or type 2 diabetes and comorbid depressive symptoms (i.e., BDI-II ≥ 14) who were randomized to either individual 8-week CBT (n = 45) or individual 8-week MBCT (n = 46). …”
  20. 17040

    Transporter inhibitor MK571 inhibited the generation and excretion of demethoxycurcumin-<i>O</i>-glucuronides in HeLa1A1 cells. by Beibei Zhang (509356)

    Published 2019
    “…<p>(A) MK571 (5 and 20 μM) inhibited the excretion of demethoxycurcumin-<i>O</i>-glucuronides (G1) in extracellular medium; (B) Inhibitory effects of MK571 (5 and 20 μM) on the excretion of demethoxycurcumin-<i>O</i>-glucuronides (G2) in extracellular solution; (C) MK571 (5 and 20 μM) decreased the efflux excretion rates of G1 and G2; (D) MK571 (5 and 20 μM) evaluated the intracellular levels of G1 and G2; (E) MK571 (5 and 20 μM) reduced the overall formation (<i>f</i><sub>met</sub>) of G1 and G2 in HeLa1A1 cell; The concentration of demethoxycurcumin was 4 μM. …”